首页> 美国卫生研究院文献>Quality in Health Care : QHC >Insights from the sharp end of intravenous medication errors: implications for infusion pump technology
【2h】

Insights from the sharp end of intravenous medication errors: implications for infusion pump technology

机译:静脉药物治疗错误的深刻见解:对输液泵技术的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Intravenous (IV) medication errors are a common type of error identified in hospitals and can lead to considerable harm. Over the past 20 years there have been several hundred FDA reported incidents involving IV pumps, many of which have led to patient deaths. >Objective: To determine the actual types, frequency, and severity of medication errors associated with IV pumps. To evaluate the likelihood that smart pump technology without an interface to other systems could have prevented errors. >Methods: Using a point prevalence approach, investigators prospectively compared the medication, dose, and infusion rate on the IV pump with the prescribed medication, doses, and rate in the medical record. Preventability with smart pump technology was retrospectively determined based on a rigorous definition of currently available technology. >Results: A total of 426 medications were observed infusing through an IV pump. Of these, 285 (66.9%) had one or more errors associated with their administration. There were 389 documented errors overall; 37 were "rate deviation" errors and three of these were judged to be due to a programming mistake. Most of the documented events would not have caused patient harm (NCC MERP category C). Only one error would have been prevented by smart pump technology without additional interface and software capabilities. >Conclusion: Medication errors associated with IV pumps occur frequently, have the potential to cause harm, and are epidemiologically diverse. Smart pumps are a necessary component of a comprehensive safe medication system. However, currently available smart pumps will fail to generate meaningful improvements in patient safety until they can be interfaced with other systems such as the electronic medical record, computerized prescriber order entry, bar coded medication administration systems, and pharmacy information systems. Future research should focus on the effectiveness of new technology in preventing latent and active errors, and on new types of error that any technology can introduce.
机译:>背景:静脉(IV)用药错误是医院识别出的常见错误类型,可能会造成相当大的伤害。在过去的20年中,已经有数百次FDA报告涉及IV泵的事故,其中许多事故导致患者死亡。 >目标:确定与IV泵相关的药物错误的实际类型,频率和严重性。为了评估没有与其他系统接口的智能泵技术可以防止错误的可能性。 >方法:研究人员使用点流行病学方法对IV泵上的药物,剂量和输液速率与病历中规定的药物,剂量和速率进行了前瞻性比较。基于当前可用技术的严格定义,回顾性地确定了智能泵技术的可预防性。 >结果:观察到总共有426种药物通过IV泵注入。其中285个(66.9%)出现一个或多个与管理相关的错误。总共记录了389个错误。 37个是“速率偏差”错误,其中三个是由于编程错误而引起的。大多数已记录的事件不会造成患者伤害(NCC MERP C类)。如果没有其他接口和软件功能,智能泵技术将只能防止一个错误。 >结论:与IV泵相关的用药错误经常发生,有可能造成伤害,并且在流行病学上也多种多样。智能泵是全面安全用药系统的必要组成部分。但是,当前可用的智能泵在将其与其他系统(例如电子病历,计算机化处方者订单输入,条形码药物管理系统和药房信息系统)接口之前,将无法在患者安全方面产生有意义的改善。未来的研究应侧重于新技术在防止潜在错误和主动错误方面的有效性,以及任何技术都可以引入的新型错误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号